Newsletter | August 27, 2024

08.27.24 -- ChatGPT-4: Practical Applications For The Biopharma Laboratory

FEATURED EDITORIAL

ChatGPT-4: Practical Applications For The Biopharma Laboratory

AI has made its way into the biopharma laboratory, and ChatGPT-4 is the most popular. Do you know the capabilities that this tech can deliver?

INDUSTRY INSIGHTS

Post-Pandemic Outsourcing Demand: How Are CDMOs Responding?

Ultimately, to serve the highly competitive biopharma and pharmaceutical markets, CDMOs must be adaptable to the culture of the company for whom they are working.

Early Solid Form Screening To Guide Drug Development

Conducting solid form screening early can help your team select and isolate the ideal lead polymorph to ensure manufacturability and stability while avoiding costs and hiccups down the road.

Engineering Approaches To Respiratory Drug Delivery

Explore the material and performance properties of spray-dried and jet-milled mannitol for respiratory delivery of crystalline mannitol.

Are Non-Human Primates A Research Dead End?

The time has come to move away from using non-human primates as test subjects in biomedical research and embrace more practical, reproducible, and cost-effective models.

mRNA-Lipid Nanoparticles Circumvent Viral Vector Limitations

Both physical and chemical nonviral gene delivery systems for ex vivo genetic modification offer advantages over viral vectors, including smaller scale production and the low risk of immunogenicity.

Bringing Allogeneic Cell Therapy To Patient Care

Bringing allogeneic cell therapy to patient care will require flexible, closed, and automated solutions to support the treatment options and increasing scale of the industry.

MOST POPULAR NEWS

Phanes Therapeutics' PT217 Receives ODD For Neuroendocrine Carcinoma From The FDA

SwRI Develops Novel DNA-Targeting Therapeutic Screening Technique

Moffitt Researchers Develop New Chemical Method To Enhance Drug Discovery

IASO Bio Receives U.S. FDA Approval Of IND App For Equecabtagene Autoleucel

Peering Into The Mind Of Artificial Intelligence To Make Better Antibiotics

BioLogic Summit To Demystify The New AI/ML Paradigm In Biologic Drug Development

Dr. Reddy's, Aurigene, & Kainomyx Sign MoU For Joint Deve Of Affordable Anti-Malarial Drug

Crown Bioscience Partners With CTI To Support Consulting Services In Oncology Drug Dev

Energesis & Akston Biosciences Partner To Focus On Companion Animal Obesity Drug Dev

IPA Successfully Engineers Antibodies Entirely Through Computer Simulations Using LENSai

Sanyou Bio's Innovative Intelligent Antibody Design oneClick+ Platform Is Officially Launched

SOLUTIONS

PBPK Predictive Modeling Services

A Semi-Automated Tangential Flow Filtration System

GMP Manufacturing